Challenges of Cell, Gene, CAR-T and the Personalized Medicine Supply Chain (WS26)

2 May 2018
Available Seats:

The attendee will be able to:

  1. Define personalized medicine.
  2. Describe the process of developing supply chains for personalized medicine.
  3. List two (2) major challenges or strategies employed for delivering a robust personalized medicine supply chain.
  4. Compare and contrast the logistics requirements of standard cold chain products versus cell and gene therapy products.
  5. List at least two (2) concerns in the handling of cell and gene therapy clinical materials.
  6. Describe the appropriate classification and labeling of cell and gene therapy products to ensure compliant transportation.

Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.